Mohd Raja

Design, synthesis and optimization of bis-amide derivatives as CSF1R inhibitors.

A. K. Agarwal, C. Higgs, S. Bernales, 2017, Bioorganic & medicinal chemistry letters.

Temozolomide analogs with improved brain/plasma ratios - Exploring the possibility of enhancing the therapeutic index of temozolomide.

Vikas Dixit, Emma McCullagh, D. T. Hung, 2016, Bioorganic & medicinal chemistry letters.

In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-a]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude Mice

N. Sharma, Raj Kumar, G. Joshi, 2022, Molecules.

Targeting prostate cancer with compounds possessing dual activity as androgen receptor antagonists and HDAC6 inhibitors.

Devleena Shivakumar, J. Lindquist, D. T. Hung, 2016, Bioorganic & medicinal chemistry letters.

Novel 3-methylindoline inhibitors of EZH2: Design, synthesis and SAR.

D. Severance, D. T. Hung, S. Bernales, 2017, Bioorganic & medicinal chemistry letters.

Targeting prostate cancer with compounds possessing dual activity as androgen receptor antagonists and HDAC6 inhibitors.

Devleena Shivakumar, J. Lindquist, S. Bernales, 2016, Bioorganic & medicinal chemistry letters.

Discovery of Pyrazolopyrimidine Derivatives as Novel Dual Inhibitors of BTK and PI3Kδ.

Emma McCullagh, S. Bernales, Anamika Thakur, 2016, ACS medicinal chemistry letters.